Free Trial

Neurocrine Biosciences (NBIX) SEC Filings & 10K Form

Neurocrine Biosciences logo
$123.29 +4.16 (+3.49%)
(As of 11/20/2024 ET)

Recent Neurocrine Biosciences SEC Filings

DateFilerForm TypeView
11/07/2024
6:42 PM
Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
6:52 PM
Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
7:31 AM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
6:02 AM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
6:04 AM
Neurocrine Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2024
8:54 AM
Neurocrine Biosciences (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
09/17/2024
3:21 PM
Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:23 PM
Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
6:00 AM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
4:00 PM
Neurocrine Biosciences (Issuer)
RASTETTER WILLIAM H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
4:06 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
4:12 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
4:21 PM
LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
4:16 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
4:18 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
4:40 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
9:51 AM
Neurocrine Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/01/2024
6:03 AM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
6:04 AM
Neurocrine Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/18/2024
3:54 PM
LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:00 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:12 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
3:45 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
3:41 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:28 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:29 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:29 PM
LYONS GARY A (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:30 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:37 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
8:36 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
8:09 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
3:38 PM
Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:51 PM
Neurocrine Biosciences (Issuer)
RASTETTER WILLIAM H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:45 PM
Neurocrine Biosciences (Issuer)
POON CHRISTINE A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
4:59 PM
Mercier Johanna (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:02 PM
Neurocrine Biosciences (Issuer)
Norwalk Leslie V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:17 PM
LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:21 PM
MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:26 PM
Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:29 PM
Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:34 PM
Neurocrine Biosciences (Issuer)
Sharp Shalini (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!
05/21/2024
4:27 PM
Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:35 PM
Neurocrine Biosciences (Issuer)
Sharp Shalini (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:15 PM
MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:57 PM
LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:06 PM
Neurocrine Biosciences (Issuer)
Norwalk Leslie V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:51 PM
Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:46 PM
Mercier Johanna (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
3:31 PM
Neurocrine Biosciences (Subject)
Norwalk Leslie V (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
3:31 PM
Neurocrine Biosciences (Subject)
Sharp Shalini (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
3:32 PM
Neurocrine Biosciences (Subject)
POPS RICHARD F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
3:40 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:23 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2024
3:26 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:01 AM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
6:03 AM
Neurocrine Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/17/2024
4:19 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:29 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
3:40 PM
Neurocrine Biosciences (Filer)
Form ARS
04/10/2024
3:31 PM
Neurocrine Biosciences (Filer)
Form DEFA14A
04/10/2024
3:07 PM
Neurocrine Biosciences (Filer)
Form DEF 14A
04/03/2024
3:44 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
5:02 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:20 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/15/2024
4:25 PM
MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:33 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:15 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:19 PM
Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
3:32 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2024
3:33 PM
MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2024
5:47 PM
Neurocrine Biosciences (Issuer)
Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
5:38 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:22 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/08/2024
3:22 PM
Neurocrine Biosciences (Subject)
POPS RICHARD F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
5:55 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
6:02 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:50 PM
Neurocrine Biosciences (Issuer)
Norwalk Leslie V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
4:11 PM
Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
4:51 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
4:40 PM
Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
4:43 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
4:45 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
4:48 PM
Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
4:27 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
4:29 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
4:33 PM
Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
4:35 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
4:38 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
4:17 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
3:18 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2024
3:19 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
This Bull Market Indicator called NVDA at $116 (Ad)

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here
02/13/2024
3:19 PM
Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2024
3:20 PM
Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2024
3:20 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2024
4:29 PM
Neurocrine Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/08/2024
6:46 PM
Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
6:35 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
6:21 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
6:25 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
6:28 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NBIX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners